Mid-term outcomes of different treatments of internal iliac artery in endovascular aneurysm repair

医学 髂内动脉 外科 跛行 髂动脉 髂总动脉 支架 腔内修复术 髂外动脉 回顾性队列研究 闭塞 动脉瘤 腹主动脉瘤 动脉疾病 血管疾病
作者
節家 直己,Jiaxue Bi,Yonghui Chen,Xiaoxing Zhang,Bin Zhao,Hao Liang,Jibo Fan,Xiangchen Dai
出处
期刊:Science Progress [SAGE Publishing]
卷期号:107 (3)
标识
DOI:10.1177/00368504241274998
摘要

Objective To evaluate the mid-term outcomes of different treatment strategies for the internal iliac artery (IIA) during EVAR. Methods This was a retrospective study. All patients undergoing EVAR, who required treatment of at least one side of IIA from January 2013 to July 2022 in a single center, were included. According to the different treatment strategies for IIA, the patients were divided into UP (unilateral preservation), BP (bilateral preservation) and BE (bilateral embolization) groups. The primary outcomes included buttock claudication, bowel ischemia and iliac-related reintervention. Then patients who underwent IIA reconstruction were divided into IPG (iliac parallel stent graft) and IBG (iliac branch stent graft) groups according to the reconstruction technique. The primary outcomes included endoleak, iliac branch occlusion and iliac-related reintervention. Results A total of 237 patients were included, including 167 in the UP group, 9 in the BP group and 61 in the BE group. The mean follow-up time was 39.0 ± 27.7, 50.0 ± 22.1 and 25.8 ± 18.9 months in UP, BP and BE groups, respectively. Thirty cases (12.7%) of buttock claudication occurred, and it was significantly higher in the BE group than the UP group (26.2% vs. 7.8%, p < 0.001). There were no significant differences in the other follow-up outcomes among three groups. The K–M analysis indicated that the patients in the BE group had a lower survival rate than those in the other two groups (p = 0.024). 24 patients underwent IIA reconstruction, including 8 in the IPG group and 16 in the IBG group. The endoleak in the IBG group was significantly lower than that in the IPG group (0% vs. 25.0%, p = 0.041). The iliac-related reintervention, iliac occlusion and mortality were similar between the two groups. Conclusion Overall it is beneficial for patients to preserve at least one side of IIA during EVAR as much as possible. Compared with IPG, IBG might be more applicable for IIA reconstruction.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
pluto应助lyang采纳,获得10
刚刚
山复尔尔应助三六九采纳,获得10
1秒前
妮妮发布了新的文献求助10
2秒前
rain发布了新的文献求助10
2秒前
2秒前
青山完成签到,获得积分20
3秒前
4秒前
小研菌完成签到,获得积分10
4秒前
董方圆完成签到,获得积分10
4秒前
何木萧发布了新的文献求助10
4秒前
4秒前
5秒前
爱笑可仁发布了新的文献求助10
5秒前
FashionBoy应助果果采纳,获得10
6秒前
KAJIKU发布了新的文献求助10
6秒前
6秒前
orixero应助坦率的可仁采纳,获得10
7秒前
赘婿应助yousheng采纳,获得10
7秒前
周先森发布了新的文献求助10
7秒前
研友_n0kjPL完成签到,获得积分0
8秒前
静宝完成签到,获得积分10
8秒前
青山发布了新的文献求助10
9秒前
醉翁发布了新的文献求助10
9秒前
Soey发布了新的文献求助10
10秒前
爆米花应助梓歆采纳,获得10
10秒前
10秒前
Just97发布了新的文献求助20
11秒前
小郭求学发布了新的文献求助10
11秒前
11秒前
11秒前
12秒前
斯文败类应助没有昵称采纳,获得10
12秒前
冷傲千秋完成签到 ,获得积分10
12秒前
今后应助小小怪采纳,获得10
13秒前
何木萧完成签到,获得积分10
14秒前
赵乂发布了新的文献求助10
14秒前
xuan完成签到,获得积分10
14秒前
AHR发布了新的文献求助10
15秒前
15秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
Christian Women in Chinese Society: The Anglican Story 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3961655
求助须知:如何正确求助?哪些是违规求助? 3507998
关于积分的说明 11139004
捐赠科研通 3240407
什么是DOI,文献DOI怎么找? 1790947
邀请新用户注册赠送积分活动 872683
科研通“疑难数据库(出版商)”最低求助积分说明 803306